Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 1997

View Archived Issues

Proteome project collaboration announced

Bigmar to enter potential collaboration; Regains rights to oncology products

Xytronyx changes name to Pacific Pharmaceuticals

Organogenesis receives FDA clearance for Graftpatch

Studies imply role of relaxin in infertility treatments

Bristol-Myers Squibb: Q2 1997 highlights

Imminent launch of Novartis' Alzheimer's disease therapy

Normiflo launched in U.S.

Living wound care product launched in Canada

Amarillo Biosciences completes enrollment for phase II study on Sjogren's syndrome

Federal district court favors Geneva in ranitidine patent litigation

EntreMed and the National Cancer Institute sign letters of intent

Shaman: Q2 1997 highlights

New angiotensin II blocker from Merck KGaA

Bayer reports LTB4 synthesis inhibitors for asthma

MMP/TNF-alpha inhibitors from Novartis

RPR seeks U.S. and European approval for estrogen/progestogen transdermal patch

Settlement reached in NeXstar and The Liposome Company patent litigation

Lidak licenses ADIFAB technology to Aurora Biosciences

Lilly and Acacia Biosciences sign research collaboration

Briana Bio-Tech acquires breast cancer detection system

Cangene signs licensing and distribution agreement for Leucotropin

Diversa reaches milestone in Finnfeeds agreement

Andaris files IND application for Quantison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...